Downregulation of glutamic-oxaloacetic transaminase 2 (GOT2) activates oxidative stress in human pancreatic ductal adenocarcinoma (PDAC) cells and inhibits the proliferation of pancreatic cancer (Yang et al., 2018). This evidence concerns the gene GOT2 and pancreatic neoplasm.